PMID: 1198087Jan 1, 1975Paper

Effects of practolol in combination with terbutaline in the treatment of hypertension and arrhythmias in asthmatic patients

Scandinavian Journal of Respiratory Diseases
H Formgren, N E Eriksson

Abstract

After a run-in period practolol was given in the dose of 100 mg twice daily to 29 patients with chronic bronchial asthma on the indication hypertension (12) and supraventricular arrhythmia (17). During the run-in period, as well as during the practolol period, a long-acting beta2-stimulator, terbutaline, was given in the dose of 5 mg three times daily. Peak expiratory flow (PEF), heart rate and blood pressure were measured under standardized conditions. No change of the lung function was observed during practolol therapy. Systolic as well as diastolic blood pressure fell significantly. The heart rhythm was normalized in 15 of the arrhythmic subjects. No subjective worsening of the asthmatic symptoms or any other side effects were noted. It is suggested that practolol can be safely used in patients prone to bronchospasm, provided a long-acting beta2-stimulating drug is given concomitantly on the usual indications for beta blockers in acute situations.

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.